GUARINO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 473
AS - Asia 283
EU - Europa 224
AF - Africa 22
Totale 1.002
Nazione #
US - Stati Uniti d'America 470
SG - Singapore 157
IT - Italia 113
HK - Hong Kong 91
NL - Olanda 51
CN - Cina 32
DE - Germania 26
CI - Costa d'Avorio 21
GB - Regno Unito 11
FI - Finlandia 5
IE - Irlanda 5
LT - Lituania 4
IN - India 3
UA - Ucraina 3
AT - Austria 2
CA - Canada 2
FR - Francia 2
BE - Belgio 1
MX - Messico 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.002
Città #
Singapore 139
Hong Kong 90
Santa Clara 80
Chandler 65
Amsterdam 46
Ashburn 29
Naples 23
Millbury 21
Council Bluffs 14
Des Moines 11
Dearborn 10
Lawrence 9
London 8
Nanjing 8
Napoli 7
Boston 6
Princeton 6
Caivano 5
Dublin 5
Afragola 4
Kronberg 4
Milan 4
Nuremberg 4
Rome 4
Seattle 4
Wilmington 4
Baronissi 3
Frankfurt am Main 3
Helsinki 3
Jacksonville 3
Legnaro 3
Schoenwalde 3
Shenyang 3
Aversa 2
Beijing 2
Florence 2
Freiburg im Breisgau 2
Lappeenranta 2
Pune 2
Sant'Antonio Abate 2
Shanghai 2
Turin 2
Verona 2
Ascoli Piceno 1
Bastia umbra 1
Bologna 1
Brussels 1
Cambridge 1
Cascina 1
Cesena 1
Dallas 1
Dalmine 1
Dongguan 1
Frattamaggiore 1
Handan 1
Hebei 1
Houston 1
Jiaxing 1
Johannesburg 1
Mexico City 1
Moscow 1
Nanchang 1
Ottawa 1
Padula 1
Palermo 1
Pisticci 1
Redmond 1
Redwood City 1
San Giorgio di Piano 1
San Giovanni Lupatoto 1
Sant'Anastasia 1
Santa Maria a Vico 1
Sedriano 1
Shijiazhuang 1
Toronto 1
Vienna 1
Totale 684
Nome #
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 54
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 45
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 43
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 42
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 40
Metabolic disorders across hepatocellular carcinoma in Italy 39
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 37
Corrigendum to "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" [J Hepatol 68 (2018) 33-41] 36
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 36
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 34
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 33
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 33
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 32
Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy 30
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 29
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 28
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 26
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 25
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 25
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 25
The interpretation of liver function tests in pregnancy 24
Pattern of macrovascular invasion in hepatocellular carcinoma 23
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 20
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study 20
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib 20
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 19
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice 19
Vascular liver diseases: A sex-oriented analysis of the literature 18
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 16
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 16
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 15
COVID-19 and Fatty Liver Disorders 15
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 14
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 14
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 13
Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease 13
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 13
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 12
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 12
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 11
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 11
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open! 10
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 8
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis 8
Tislelizumab: a promising alternative first-line systemic therapy in unresectable advanced hepatocellular carcinoma 8
Totale 1.064
Categoria #
all - tutte 6.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 3 1 1 0 0 0
2020/202147 4 0 2 1 11 9 16 0 2 0 1 1
2021/202298 0 0 0 0 1 1 0 4 0 14 40 38
2022/2023200 15 4 3 6 34 23 3 11 24 51 23 3
2023/2024246 6 75 41 20 5 13 2 29 1 13 28 13
2024/2025420 71 70 0 24 41 104 110 0 0 0 0 0
Totale 1.064